The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
View Top Employees from Bluejay TherapeuticsWebsite | http://www.bluejaytx.com |
Employees | 19 (14 on RocketReach) |
Founded | 2020 |
Industry | Biotechnology Research |
Looking for a particular Bluejay Therapeutics employee's phone or email?
14 people are employed at Bluejay Therapeutics.